U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-QSB/A
                                Amendment No. 1

[x]     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
        ACT OF 1934

        For the quarterly period ended June 30, 2005.

[ ]     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
        ACT OF 1934

                        COMMISSION FILE NUMBER: 000-28519

                                   ZANN CORP.
                 (Name of small business issuer in its charter)

                     NEVADA                                    76-0510754
         (State or other jurisdiction of                    (I.R.S. Employer
          incorporation or organization)                   Identification No.)

1549 N. LEROY ST., SUITE D-200, FENTON, MICHIGAN                  48430
    (Address of principal executive offices)                    (Zip Code)

                                 (810) 714-2978
                          (Issuer's telephone number)


     Check  whether  the issuer (1) filed all reports required to be filed by
Section 13  or  15(d) of the Exchange Act during the past 12 months (or for such
shorter period  that the registrant was required to file such reports), and (2)
has been subject  to  such  filing  requirements for the past 90 days.
                                Yes [x]  No [ ]

     State  the  number of shares outstanding of each of the issuer's classes of
common  equity,  as  of  the  latest practicable date: As of August 3, 2005, the
issuer  had  28,020,296  shares  of  its  common  stock  issued  and
outstanding.

     Transitional Small Business Disclosure Format (check one): Yes [ ]  No [x]


<PAGE>
<TABLE>
<CAPTION>
                                TABLE OF CONTENTS
<S>                                                                         <C>
PART I - FINANCIAL INFORMATION . . . . . . . . . . . . . . . . . . . . . .   1
     Item 1.  Financial Statements (Unaudited) . . . . . . . . . . . . . .   1
              Condensed Consolidated Balance Sheets. . . . . . . . . . . .   1
              Condensed Consolidated Statement of Losses . . . . . . . . .   2
              Condensed Consolidated Statements of Cash Flow . . . . . . .   3
              Notes for Condensed Consolidated Financial Statements. . . .   3
     Item 2.  Management's Discussion and Analysis or Plan of Operation. .  13
     Item 3.  Controls and Procedures. . . . . . . . . . . . . . . . . . .  17
PART II - OTHER INFORMATION. . . . . . . . . . . . . . . . . . . . . . . .  17
     Item 1.  Legal Proceedings. . . . . . . . . . . . . . . . . . . . . .  18
     Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.  18
     Item 3.  Submission of Matters to a Vote of Security Holders. . . . .  19
     Item 4.  Other Information. . . . . . . . . . . . . . . . . . . . . .  19
     Item 5.  Exhibits . . . . . . . . . . . . . . . . . . . . . . . . . .  19
SIGNATURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
</TABLE>


<PAGE>
                         PART I - FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS.

<TABLE>
<CAPTION>
                                                 ZANN CORP.
                                    CONDENSED CONSOLIDATED BALANCE SHEETS

                                                                            June 30, 2005  December 31, 2004
                                                                             (Unaudited)
<S>                                                                        <C>             <C>

ASSETS
------
Current Assets
  Cash and cash equivalents                                                $       7,496   $         39,890
  Inventory (Note D)                                                             103,871             16,397
  Prepaid expenses and other                                                       1,506              2,314
    Total Current Assets                                                         112,873             58,601

  Property and equipments, net of accumulated depreciation of $0               2,068,707                  0

  Other Assets

Intangibles Assets, net (Note C)                                               2,764,263                  -

Total Assets                                                               $   4,945,843   $         58,601

LIABILITIES AND DEFICIENCY IN STOCKHOLDERS' EQUITY
--------------------------------------------------

Current Liabilities
  Accounts payable and accrued liabilities (Note E)                        $     867,075   $        704,934
  Account payable-related party                                                  103,656              1,600
  Notes payable-others (Note F)                                                1,848,440             30,000
    Total Current Liabilities                                                  2,819,171            736,534
Notes Payable-Long Term                                                        3,005,653                  -
    Total Liabilities                                                          5,824,824            736,534

Minority Interest (Note B)                                                       199,532                  -
Deficiency in Stockholders' Equity (Note G)

  Common stock, $.001 par value, 4,000,000,000 shares authorized,                 22,325                660
  22,324,583 and 659,399 shares issued and outstanding respectively.
  Subscription receivable                                                        (65,000)           (39,616)
  Preferred Stock,
    Series A, $.001 par, 20,000,000 shares authorized, 2,497,700 and               2,498              2,438
    2,437,700 shares issued and outstanding, at June 30, 2005 and
    December 31, 2004, respectively
    Series B, par value $.001; authorized 1,250,000; 50,000 and 0 shares              50                  -
    issued and outstanding at June 30, 2005 and December 31, 2004,
    respectively
    Series C, $.001 par, 25,000,000 shares authorized 10,000,000 shares           10,000             10,000
    issued and outstanding at June 30, 2005 and December 31, 2004
  Additional paid-in-capital                                                  36,586,555         35,468,213
  Accumulated deficit                                                        (37,634,940)       (36,119,628)
    Total (Deficiency) in Stockholders' Equity                                (1,078,512)          (677,933)

Total Liabilities and (Deficiency) in Stockholders' Equity                 $   4,945,843   $         58,601
<FN>

See accompanying notes to unaudited condensed consolidated financial statements
</TABLE>


                                      -1-
<PAGE>
<TABLE>
<CAPTION>
                                                          ZANN CORP.
                                          CONDENSED CONSOLIDATED STATEMENT OF LOSSES
                                                         (UNAUDITED)

                                               For the three months ended June 30        For the six months ended June 30
                                                  2005                  2004                2005                 2004
                                                                   (Restated-Note J)                        (Restated-Note J)
<S>                                        <C>                   <C>                 <C>                   <C>
REVENUES                                   $               254   $               -   $               599   $               -
Cost of Goods Sold                                         677                   -                 1,116                   -
                                           --------------------  ------------------  --------------------  ------------------
    Gross  (Loss)                                         (424)                  -                  (518)                  -

OPERATING EXPENSES
    Selling, General &
    Administrative                                     369,737             714,327             1,310,823           1,987,268
                                           --------------------  ------------------  --------------------  ------------------

(LOSS) FROM OPERATIONS                                (370,161)           (714,327)          ( 1,311,341)         (1,987,268)

Other Income (Expense)
    Interest Income (Expense)-
    net                                                 (2,494)                  -                (4,439)                  -
    Debt Forgiveness                                         -             606,728                     -             616,132
                                           --------------------  ------------------  --------------------  ------------------
      Total Other Income
      (Expense)                                         (2,494)            606,728                (4,439)            616,132
NET (LOSS) BEFORE PROVISION
FOR INCOME TAX                                        (372,655)           (107,599)           (1,315,780)         (1,371,136)
PROVISION FOR INCOME TAX

NET (LOSS)                                 $          (372,655)  $        (107,599)  $        (1,315,780)  $      (1,371,136)
                                           ====================  ==================  ====================  ==================

Loss per share (basic and fully diluted)   $             (0.02)  $          (43.85)  $             (0.11)  $         (571.31)
Basic and diluted weighted average
number of shares outstanding as restated
for reverse and forward stock splits                17,773,067               2,454            12,083,906               2,400
<FN>

See accompanying notes to unaudited condensed consolidated financial statements
</TABLE>


                                      -2-
<PAGE>
<TABLE>
<CAPTION>
                                            ZANN CORP.
                          CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
                                           (UNAUDITED)

                                                             For the six months ended June 30,
                                                                 2005              2004
<S>                                                       <C>                <C>
  Net (Loss)                                              $     (1,315,780)  $        (1,371,136)
  Adjustments to reconcile net (loss)
    to net cash used in operating activities:
    Common stock issued for services                               272,300               607,395
    Employee stock option expense                                  449,295               401,812
    Preferred series A issued for services                             900
    Reimbursement due from a related party and paid
      in stock after the period-end                                      -              (150,000)
    Debt forgiven                                                        -              (616,132)
  Changes in:
    Accounts payable and accrued expenses                          103,814              (255,709)
    Inventory and prepaid expenses                                   2,361                     -
    Note payable-related                                                 -               (90,000)
                                                          ---------------------------------------
Net Cash  (used) in Operating Activities                          (487,110)           (1,473,770)
                                                          ---------------------------------------

Cash Flows from Investing Activities
  Cash acquired on acquisition of Sartam                               394

  Acquisition of subsidiary                                       (200,000)                    -
                                                          -----------------
Net Cash provided (used) in Investing Activities                  (199,606)

Cash Flows from Financing Activities:
  Proceeds from convertible debenture                              100,000                     -
  Proceeds from notes payable                                      200,000
  Payments on convertible debenture                                 (1,615)                    -
  Proceeds from sale of common stock                               355,937             1,230,388
                                                          ---------------------------------------
Net Cash provided (used) in Financing Activities                   654,322             1,230,388
                                                          ---------------------------------------
Net Change in Cash                                                 (32,394)             (243,382)
Cash at beginning of period                                         39,890               357,493
                                                          ---------------------------------------
Cash at end of period                                     $          7,496   $           114,111
                                                          =======================================


Supplemental Disclosures of Cash Flow Information:

  Cash paid during the period for interest                $          4,439   $                 -
                                                          ---------------------------------------
  Cash paid during the period for income taxes            $              -   $                 -
                                                          ---------------------------------------
  Common stock issued in exchange for services rendered   $        272,300   $           607,395
                                                          ---------------------------------------
  Preferred shares issued for services                    $            900   $                 -
                                                          ---------------------------------------
  Preferred shares issued for debt                        $         36,300   $         3,022,550
                                                          ---------------------------------------
  Employee stock option expense                           $        449,295   $           401,812
                                                          ---------------------------------------
  Income from Liabilities forgiven                        $              -   $           616,132
                                                          ---------------------------------------
  Acquisition: (Note B and C)
                                                          ---------------------------------------
      Assest acquired                                     $      4,922,392   $                 -
                                                          ---------------------------------------
      Liabilities assumed                                 $       (522,392)  $                 -
                                                          ---------------------------------------
      Cash paid                                           $       (200,000)  $                 -
                                                          ---------------------------------------
      Notes payable                                       $     (4,200,000)  $                 -
                                                          ---------------------------------------
<FN>

See accompanying notes to unaudited condensed consolidated Financial Statements
</TABLE>


                                      -3-
<PAGE>
                                   ZANN CORP.
         NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                                  JUNE 30, 2005


NOTE  A  -  SUMMARY OF ACCOUNTING POLICIES

GENERAL

The accompanying unaudited condensed consolidated financial statements have been
prepared  in  accordance  with  accounting  principles generally accepted in the
United  States  of  America  for  interim  financial  information  and  with the
instructions  to  Form  10-QSB.  Accordingly,  they  do  not  include all of the
information  and  footnotes required by generally accepted accounting principles
for  complete  financial  statements.

In  the  opinion  of management, all adjustments (consisting of normal recurring
accruals)  considered  necessary  for  a  fair  presentation have been included.
Accordingly, the results from operations for the six-month period ended June 30,
2005  are not necessarily indicative of the results that may be expected for the
year  ending  December  31, 2005. The unaudited condensed consolidated financial
statements should be read in conjunction with the consolidated December 31, 2004
financial  statements  and  footnotes thereto included in the Company's SEC Form
10-KSB.

BUSINESS AND BASIS OF PRESENTATION

The  Company  incorporated  in  Florida on March 4, 1999 as Investra Enterprises
Inc.  On  March  6,  2000,  we  completed  a  Share  Purchase Agreement in which
Pathobiotek  Diagnostics,  Inc.,  a  Texas  Corporation,  acquired  all  of  our
issued  and  outstanding  shares  for  $150,000  for the purpose of completing a
merger  of  Pathobiotek  Diagnostics, Inc. and Investra Enterprises. Pathobiotek
Diagnostics,  Inc.,  a  Texas  corporation,  was  the  surviving  entity.

Effective  September 7, 2001, we implemented a reverse split of our common stock
at  the  ratio  of  one  post-consolidation  share for each 40 pre-consolidation
shares,  except  that  no  shareholder  was  reduced  to  less  than  10 shares.

On  October  16,  2001, we completed the Plan and Agreement of Reorganization by
and  between  Pathobiotek  Diagnostics  Inc.,  ATNG  Acquisition,  Inc., a Texas
corporation,  and  ATNG,  Inc.,  a  Nevada  corporation  under which Pathobiotek
Diagnostics  Inc.  issued 27,836,186 shares of its common stock as consideration
for  its  wholly owned subsidiary, ATNG Acquisition, Inc. to acquire 100 percent
of  the  issued  and  outstanding  stock  of  ATNG,  Inc., a Nevada corporation.

Following  the October 16, 2001 reorganization, ATNG Acquisition, Inc. and ATNG,
Inc. merged. On October 17, 2001, we changed our name to ATNG, Inc. On September
6,  2003  we  changed  our domicile from Texas to Nevada and changed our name to
ATNG  Inc.

On August 10, 2004, the Company acquired Blue Kiwi, Inc., a Michigan Corporation
engaged  in  the  marketing and sale of nutritional supplements. Blue Kiwi, Inc.
currently  markets  two  lines  of  products:  Fatigue Pack(R) and PMS(TM) Pack.

In  November  2004,  the  shareholders  and  directors of the Company approved a
change  in  the  name  of the Company from ATNG, Inc. to Zann Corp., amended its
Articles  of  Incorporation,  increasing  the  number  of  authorized  shares to
4,000,000,000 and authorized a reverse stock split effective December 3, 2004 of
one  post consolidation share for every 900 pre-consolidation share. On March 1,
2005  the  sole  Director  approved  a  decrease  in  the  authorized  shares to
11,428,572  and authorized a reverse stock split effective March 10, 2005 of one
post  consolidation  share  for  every  350  pre-consolidation  share.  On April
19,  2005  the  Sole Director approved a forward stock split of three shares for
every  one  share held as of May 3, 2005.  The accompanying financial statements
reflect  these  changes.  Accordingly,  all historical  weighted  average  share
and  per  share  amounts have been restated to reflect  the  reverse and forward
stock  splits. In addition the meeting approved and increase in  the  number  of
shares  of  Preferred  Stock  to  350,000,000  and  increased  the  authorized
number  of  common  shares  to  4,000,000,000.


                                      -4-
<PAGE>
On  June 27, 2005 the Company acquired approximately 48% of the Common and 6.52%
of  the Convertible Preferred Second Series of Sartam Industries, Inc, a Florida
Corporation  engaged  the  manufacturing and sale of automatic riveting machines
and  the  re-supply of riveting belts. We are presently evaluating the assets of
Sartam  Industries,  Inc.  and  as a result no amounts have been included in the
consolidated  financial  statements  except for the acquisition cost and related
notes  payable.

The  consolidated  financial statements include the accounts of the Company, and
its  wholly-owned  subsidiary,  Blue  Kiwi,  Inc.  Significant  intercompany
transactions  have  been  eliminated  in  consolidation.

INVENTORY

The  Company  values  inventory  at  the first in, first out basis. Inventory is
reviewed  periodically  for obsolescence and any unsaleable products are written
off.  Health  and  nutritional  supplements  are  purchased  from  an  outside
manufacturer  and include all costs including labeling and packaging. Rivet guns
and  magazines  are  manufactured  and  include  all  direct  and indirect costs
associated  with  the  manufacturing.

PROPERTY  AND  EQUIPMENT

Costs  for  property  and  equipment  are  accumulated in work in progress until
assets  are  placed in service at which time the accumulated cost is depreciated
or  amortized  over  the  estimated  useful  life  of  the  asset.

Major  classes  of property and equipment at June 30, 2005 and December 31, 2004
consist  of  the  following:

<TABLE>
<CAPTION>
                                                    2005      2004
                                                 ----------  -------
<S>                                              <C>         <C>
Equipment-computer and trucks                    $   43,707  $   --
Packing machines                                  2,025,000      --

Net property and equipment                       $2,068,707  $   --
                                                 ==========  =======
</TABLE>

IMPAIRMENT  OF  LONG-LIVED  ASSETS

The  Company  has  adopted  Statement  of Financial Accounting Standards No. 121
(SFAS  121).  The  Statement  requires  that  long-lived  assets  and  certain
identifiable intangibles held and used by the Company be reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of
an  asset  may  not  be  recoverable.  SFAS  No.  121 also requires assets to be
disposed  of  be  reported at the lower of the carrying amount or the fair value
less  costs  to  sell. Intangibles acquired in the acquisition of Sartam will be
accounted  according  to SFAS 142. Such determination will be made by management
subsequent  to  June  30,  2005.

SEGMENT  INFORMATION

The  Company  has  various  separate,  reportable  segments  under  Statement of
Financial  Accounting  Standards  No.  131,  Disclosures  about  Segments  of an
Enterprise and Related Information ("SFAS 131").  SFAS establishes standards for
reporting  information  regarding  operating  segments  in  annual  financial
statements  and requires selected information for those segments to be presented
in  interim financial reports issued to stockholders.  SFAS 131 also establishes
standards  for  related  disclosures  about products and services and geographic
areas.  Operating  segments  are identified as components of an enterprise about
which separate discrete financial information is available for evaluation by the
chief  operating  decision  maker, or decision making group, in making decisions
how  to  allocate  resources  and assess performance.  The information disclosed
herein,  materially  represents  all of the financial information related to the
Company's  principal  operating  segments.

RECLASSIFICATIONS

Certain  reclassifications  have been made in prior periods financial statements
to  conform  to  classifications  used  in  the  current  period.


                                      -5-
<PAGE>
REVENUE  RECOGNITION

For  revenue  from  product  sales, the Company recognizes revenue in accordance
with  Staff  Accounting  Bulletin No. 104, REVENUE RECOGNITION ("SAB104"), which
superseded  Staff  Accounting Bulletin No. 101, REVENUE RECOGNITION IN FINANCIAL
STATEMENTS  ("SAB101").  SAB  101  requires that four basic criteria must be met
before  revenue  can  be  recognized:  (1) persuasive evidence of an arrangement
exists;  (2)  delivery  has  occurred;  (3)  the  selling  price  is  fixed  and
determinable;  and  (4)  collectibility  is reasonably assured. Determination of
criteria  (3)  and  (4)  are based on management's judgments regarding the fixed
nature of the selling prices of the products delivered and the collectibility of
those  amounts.  Provisions  for  discounts  and rebates to customers, estimated
returns  and  allowances,  and  other  adjustments  are provided for in the same
period  the related sales are recorded. The Company defers any revenue for which
the  product has not been delivered or is subject to refund until such time that
the  Company  and  the  customer  jointly  determine  that  the product has been
delivered  or  no  refund will be required. SAB 104 incorporates Emerging Issues
Task  Force 00-21 ("EITF 00-21") MULTIPLE-DELIVERABLE REVENUE ARRANGEMENTS. EITF
00-21  addresses  accounting  for  arrangements that may involve the delivery or
performance  of  multiple  products,  services  and/or rights to use assets. The
effect  of  implementing  EITF  00-21  on  the  Company's consolidated financial
position  and  results  of  operations  was  not  significant.  For  the  period
ended  June  30,  2005  neither  of  the  Company's subsidiaries had significant
revenue.  Revenue  recognized the third and fourth quarter will be in conformity
with  the  Revenue Recognition policy enumerated above.  Revenue for Sartam will
be  recognized  when  finished  products  are  shipped  to  the customer against
confirmed  purchase  orders  or  contracts.

STOCK  BASED  COMPENSATION

In  December  2002,  the  FASB  issued SFAS No. 148, "Accounting for Stock-Based
Compensation-Transition and Disclosure-an amendment of SFAS 123." This statement
amends  SFAS  No.  123,  "Accounting  for  Stock-Based Compensation," to provide
alternative methods of transition for a voluntary change to the fair value based
method  of  accounting for stock-based employee compensation.  In addition, this
statement  amends  the  disclosure  requirements  of  SFAS  No.  123  to require
prominent  disclosures in both annual and interim financial statements about the
method of accounting for stock-based employee compensation and the effect of the
method  used on reported results.  The Company has chosen to continue to account
for  stock-based compensation using the intrinsic value method prescribed in APB
Opinion  No.  25 and related interpretations.  Accordingly, compensation expense
for stock options is measured as the excess, if any, of the fair market value of
the  Company's  stock  at  the  date of the grant over the exercise price of the
related option. The Company has adopted the annual disclosure provisions of SFAS
No.  148  in  its financial reports for the year ended December 31, 2003 and has
adopted  the  interim  disclosure  provisions  for its financial reports for the
subsequent periods. The Company does not have any awards of stock-based employee
compensation  issued  and  outstanding  at  June  30,  2005.

On  December  16,  2004,  the Financial Accounting Standards Board (FASB) issued
FASB  Statement  No.  123R  (revised  2004),  "Share-Based  Payment"  which is a
revision  of  FASB Statement No. 123, "Accounting for Stock-Based Compensation".
Statement  123R  supersedes  APB opinion No. 25, "Accounting for Stock Issued to
Employees",  and  amends  FASB  Statement  No.  95,  "Statement  of Cash Flows".
Generally,  the  approach in Statement 123R is similar to the approach described
in  Statement 123.  However, Statement 123R requires all share-based payments to
employees,  including  grants of employee stock options, to be recognized in the
income  statement based on their fair values.  Pro-forma disclosure is no longer
an  alternative.  On  April  14, 2005, the SEC amended the effective date of the
provisions  of  this statement.  The effect of this amendment by the SEC is that
the Company will have to comply with Statement 123R and use the Fair Value based
method  of  accounting  no later than the first quarter of 2006.  Management has
not  determined  the  impact  that  this  statement  will  have  on  Company's
consolidated  financial  statements.

NEW  ACCOUNTING  PRONOUNCEMENTS

In March 2005, the FASB issued FASB Interpretation (FIN) No. 47, "Accounting for
Conditional  Asset  Retirement  Obligations, an interpretation of FASB Statement
No.  143,"  which requires an entity to recognize a liability for the fair value
of  a  conditional  asset retirement obligation when incurred if the liability's
fair  value  can  be  reasonably estimated. The Company is required to adopt the
provisions  of FIN 47 no later than its last quarter of fiscal 2006. The Company
does not expect the adoption of this Interpretation to have a material impact on
its  consolidated  financial  position,  results  of  operations  or cash flows.
In  May  2005 the FASB issued Statement of Financial Accounting Standards (SFAS)
No. 154, "Accounting Changes and Error Corrections, a replacement of APB Opinion
No. 20 and FASB Statement No. 3." SFAS 154 requires retrospective application to
prior  periods' financial statements for changes in accounting principle, unless
it  is  impracticable  to  determine  either  the period-specific effects or the
cumulative  effect  of  the  change.  SFAS  154 also requires that retrospective
application  of  a  change  in


                                      -6-
<PAGE>
accounting  principle  be  limited to the direct effects of the change. Indirect
effects  of  a  change  in  accounting  principle,  such  as  a  change  in
non-discretionary  profit-sharing  payments resulting from an accounting change,
should  be  recognized  in  the  period  of the accounting change. SFAS 154 also
requires  that  a  change in depreciation, amortization, or depletion method for
long-lived,  non-financial  assets  be  accounted  for as a change in accounting
estimate effected by a change in accounting principle. SFAS 154 is effective for
accounting  changes  and  corrections  of  errors made in fiscal years beginning
after  December 15, 2005. Early adoption is permitted for accounting changes and
corrections  of  errors  made  in  fiscal  years  beginning  after the date this
Statement  is  issued.  The Company does not expect the adoption of this SFAS to
have  a  material  impact  on  its  consolidated  financial position, results of
operations  or  cash  flows.


NOTE  B  -  MINORITY INTERESTS AND ACQUISITIONS

MINORITY INTERESTS
Minority interest reflects the other owners' proportionate share in the assets,
liabilities and equity of business ventures as of the date of purchase, adjusted
by the proportionate share of post-acquisition income or loss.  As the operating
results of entities with minority interest are consolidated, minority interests
income, net represents the income or loss attributable to the other owners.

ACQUISITIONS
On August 10, 2004, the Company acquired Blue Kiwi, Inc., a Michigan Corporation
engaged  in  the  marketing  and  sale  of  nutritional supplements. The Company
entered  into  an  acquisition  agreement  with Robert C. Simpson, the Company's
president, chief executive officer, and majority shareholder, to purchase all of
the  issued  and  outstanding  capital  stock  of  Blue  Kiwi  Inc.,  a Michigan
corporation, for the sum of $5 million, payable in monthly installments of up to
10  percent of our gross profit. The obligation to pay $5 million to Dr. Simpson
in  connection  with  the  Blue  Kiwi  is expressly conditioned upon the Company
generating  profit.  In  the absence of profits, obligation to pay $5 million to
Dr.  Simpson  is without effect. The obligation will not bear any interest. As a
result  of  the  Acquisition,  Blue Kiwi became our wholly-owned subsidiary. The
following  is  the  summary  of  assets  acquired  and  liabilities  assumed and
consideration  paid  relating  to  the  transaction:  assets  acquired:

<TABLE>
<CAPTION>
<S>                        <C>
Cash                       $ 10,612
Other current assets          3,256
                           ---------
Total assets acquired        13,868
Accounts payable              9,548
Due to related party        299,600
                           ---------
Total liabilities assumed   309,148
Cash paid                    (1,000)
                           ---------
Goodwill                   $296,280
                           ---------
</TABLE>

The acquisition was accounted for as a purchase in accordance with SFAS 141 and,
accordingly, the operating results of the acquired company have been included in
the  Company's  consolidated financial statements since the date of acquisition.

In  June  2005, the Company acquired a 48% interest in Sartam, Inc. for $200,000
in  cash  and  $4,200,000  in  Promissory  Notes.  The acquisition of Sartam was
accounted  for  using the purchase method in accordance with SFAS 141, "Business
Combinations."  The  results  of operations for Sartam have been included in the
condensed  consolidated statements of losses for the three months ended June 30,
2005,  since the date of acquisition i.e. June 27, 2005. Sartam did not have any
operations  for  period  between  June 27, 2005 and June 30, 2005. In accordance
with  Financial  Accounting  Standard (SFAS) No. 141, Business Combinations, the
total  purchase  price  was  allocated  to  the  estimated  fair value of assets
acquired  and  liabilities  assumed.  The  estimate  of fair value of the assets
acquired  was  based  on  management's  estimates.  The total purchase price was
allocated  to  the  assets  and  liabilities  acquired  as  follows:

<TABLE>
<CAPTION>
<S>                          <C>
Assets acquired:
Cash                         $        395
Inventory                          89,027
Property and equipments-net     2,068,707
Intangibles                     2,764,263
                             -------------
                                4,922,392

Liabilities assumed              (522,392)
Cash paid                        (200,000)
Notes payable                $ (4,200,000)
                             -------------
                             $ (4,922,392)
                             =============
</TABLE>


                                      -7-
<PAGE>
Information  required  to  complete  the  purchase  price allocation for certain
tangible  and intangible property is not yet available.  Final allocation of the
purchase  price will be completed as soon as this information is available.  The
remaining  52%  is  owned by approximately 100 shareholders and is recognized as
minority  interest.  Sartam manufactures and sells patented Rivet Guns and Rivet
Belts  to  the  manufacturing  industry.   Operating  results  are  consolidated
consistent  with  the  acquisition  date  of  June  27,  2005.

Sartam  Industries,  Inc.  is  the  Worldwide  patent  and license holder of the
AUTOFAST(R)  2000  Fastening  System.  The AUTOFAST 2000 semi-automatic riveting
system  is  comprised  of  the AUTOFAST 2000 riveting tool and magazine. The key
feature  of  this  innovative  product  is  its  patented rivet magazine feeding
system.  The  magazine  feature enables the user to semi-automatically feed most
conventional  and structural blind rivets through a portable hand-held tool with
greater speed and reliability than current technology allows.  The AUTOFAST 2000
is cost-effective, saving time and money by increased worker productivity. It is
fast  and  efficient,  simple  and  easy  to  use, versatile, and compatible and
adaptable  to  other  systems. Applications for the AUTOFAST 2000 are limitless.
Its portable, user-friendly design makes it ideal for fieldwork and use in tight
corners and hard-to-reach places.  The AUTOFAST 2000 is the only self-contained,
portable,  semi-automatic  blind  rivet  application  tool  on the market today.


NOTE  C  -  GOODWILL  AND  OTHER  INTANGIBLE  ASSETS  -  ADOPTION  OF  SFAS  142

The  Company  has  adopted  Statement  of Financial Accounting Standards No. 142
"Goodwill  and  Other  Intangible Assets" (SFAS No. 142). SFAS No. 142 addresses
how  intangible  assets  that are acquired individually or with a group of other
assets  should  be accounted for in financial statements upon their acquisition.
This  statement  requires  goodwill amortization to cease and for goodwill to be
periodically  reviewed  for  impairment. Under SFAS No. 142, goodwill impairment
occurs  if  the  net  book  value of a reporting unit exceeds its estimated fair
value.  The Company's goodwill asset was with regard to the acquisitions of Blue
Kiwi  for $296,280. The test completed in the last quarter ended on December 31,
2004  indicated that the recorded book value of reporting unit exceeded its fair
value,  as  determined by discounted cash flows. The decrease in fair value is a
result  of:

     -    Significant operating losses during the past six months
     -    Unanticipated decline in revenues and profitability
     -    Loss of key personnel

As  a result of these events and circumstances, Company management believes that
more  likely  than  not the fair value of the reporting unit's goodwill has been
reduced  below  its  carrying  value.  As  a  result,  management  performed  an
evaluation  of  the reporting unit's tangible and intangible assets for purposes
of  determining  the  implied  fair value of goodwill at December 31, 2004. Upon
completion  of  the assessment, management recorded a non-cash impairment charge
of  $(296,280),  net of tax, or $(23.16) per share, to reduce the carrying value
of  goodwill  in  this  reporting  unit  to  its  estimated  value  of  $0.

The  Company  does not have complete information relating to intangible property
acquired  with  Sartam  acquisition.  The  Company  will  perform  allocation of
purchase  price, including intangibles and related impairment test subsequent to
June  30,  2005.

Considerable  management  judgment  is  necessary  to  estimate  fair  value.
Accordingly,  actual  results  could  vary  significantly  from  managements'
estimates.


NOTE  D  -  INVENTORIES

Inventories  are  stated  at  the  lower  of  cost  or  market determined by the
first-in,  first-out  (FIFO)  method.  At  As  of  June  30,  2005,  inventories
consist  of  pre-packaged  Health  and  Nutritional  supplements  of $14,844 and
Manufactured  Rivet  Guns  and  Belts  of  $89,027  available  for  sale  to
customers.

Components  of  inventories  as  of  June  30, 2005 and  December 31,2004 are as
follows:

<TABLE>
<CAPTION>
<S>             <C>       <C>
                    2005     2004
                --------  -------
Finished Goods  $103,871  $16,397
</TABLE>


                                      -8-
<PAGE>
NOTE  E  -  ACCOUNTS  PAYABLE  AND  ACCRUED  LIABILITIES

Accounts  payable  and  accrued  liabilities  at  June  30,  2005  and  December
31,2004  consist  of  the  following:

<TABLE>
<CAPTION>
                    2005      2004
                  --------  --------
<S>               <C>       <C>
Accounts payable  $494,357  $346,801
Accrued salaries   137,788   116,903
Payroll taxes      234,930   234,930
Accrued interest         -     6,300
                  ------------------
Total             $867,075  $704,934
                  --------  --------
</TABLE>

NOTE  F  -  NOTES  PAYABLE

NOTES  PAYABLE  AT JUNE 30, 2005 AND  DECEMBER  31,  2004  ARE  AS  FOLLOWS:

<TABLE>
<CAPTION>
                                                                                  2005       2004
                                                                           ------------  ---------
<S>                                                                        <C>           <C>
Convertible Debenture, due April 1, 2005, interest 12%, convertible into
180,000 preferred shares-series A. On April 1, 2005 the holder of this
debenture agreed to accept 50,000 shares of preferred shares-series B.     $         -   $ 30,000
                                                                           ------------  ---------
Convertible Debenture, due January 1, 2006, interest 10%, payable
1,000 per month, convertible into 15,000  preferred shares-series A on
a basis of $.663 cents for each share converted                                 98,440          -
                                                                           ------------  ---------
Promissory Notes, Non-Interest Bearing, due  $500,000 in December
2005; $1,000,000 in March 2006 and $2,700,000 in August 2006                 4,200,000          -
                                                                           ------------  ---------
Promissory Note, Non-Interest Bearing, due in August 2005,
collateralized by 20,000 shares of Preferred Series A                          150,000          -
                                                                           ------------  ---------
Promissory Note, Non-Interest Bearing, due in August 2005,
collateralized by 7,000 shares of Preferred Series A                            50,000          -
                                                                           ------------  ---------
Promissory Note, Non-Interest Bearing, due from royalties or revenue
from Honsel until paid in full.  If not paid from royalties or revenue
from Honsel then $50,000 due December 31, 2005 and remaining
balance due by December 31, 2006.                                              355,653          -
                                                                           ------------  ---------

Total                                                                        4,854,093     30,000
Less: current portion                                                       (1,848,440)   (30,000)
                                                                           ------------  ---------

Notes payable: long-term                                                   $ 3,005,653   $      -
                                                                           ============  =========
</TABLE>


NOTE  G  -  CAPITAL STOCK

On  December  3,  2004, the Shareholders and Directors of the Company approved a
change  in  the  name  of  the Company from ATNG, Inc. to Zann Corp. and amended
its  Articles  of  Incorporation; increasing  the  number  of  authorized shares
to  4,000,000,000,  and  authorizing a reverse stock split effective December 3,
2004  of  one post consolidation share for every 900 pre-consolidation share. On
March  1,  2005  the  sole  Director  approved  a  decrease  in  the  authorized
shares  to  11,428,572  and authorized a reverse stock split effective March 10,
2005  of one post  consolidation  share  for  every 350 pre-consolidation share.
On  April  19,  2005  the sole Director approved a forward split of 3 shares for
every 1 share outstanding effective May 3, 2005. The sole Director also approved
increasing  the  authorized  number  of  common  shares to 4,000,000,000 and the
authorized  preferred  shares  to  350,000,000.  The  accompanying  financial
statements  reflect  these  changes.  Accordingly,  all  historical  weighted
average  share  and  per  share  amounts  have  been  restated  to  reflect  the
reverse  and  forward  stock  splits.

COMMON STOCK

The  Company  is  authorized to issue 4,000,000,000 shares of common stock, with
$0.001  par  value  per  share.  As  of  June 30, 2005 and December 31, 2004 the
Company has issued and outstanding 22,324,583 and 659,399 shares respectively of
common  stock  with  par  value  of  $0.001  per  share.

During  the  six  months  ended  June  30,  2005 and 2004, the Company issued an
aggregate  of  14,192,327 and  1,980 shares for employee stock incentive program
for  $830,616  and  $1,632,200  respectively.  In  relation  to  issuance


                                      -9-
<PAGE>
of shares for employee  stock  incentive  program,  the Company received cash of
$355,937 and $1,230,387  respectively  and recorded  a  subscription  receivable
at  June  30,  2005  of  $65,000.  The  Company  recorded  $449,295 and $401,813
respectively as employee compensation expenses for the six months ended June 30,
2005  and  2004.

During  the  six  months  ended  June  30,  2005 and 2004, the Company issued an
aggregate  of  7,472,857  and  383  shares respectively for various professional
services  valued  at  $272,300 and $607,395 respectively. The Company valued the
shares  issued  at  the  closing price on the date the shares were issued, which
approximated the fair value of the services rendered.  The compensation costs of
$272,300  and  $607,395  were  charged  to  operations  during  the  six  months
ended  June  30,  2005  and  2004  respectively.

The  Company  accounts  for  its  employee  stock-based compensation plans under
Accounting  Principles Board ("APB") Opinion No. 25, Accounting for Stock Issued
to  Employees.  The  Company  granted  14,192,327  and  1,980  options  to
purchase  common  stock  to employees  in  the six month periods  ended June 30,
2005  and  2004,  respectively.  All  options vest immediately, have an exercise
price  of  90  percent  of market value on the date of grant and expire 10 years
from  the  date of grant. All options are exercised on the day of grant. At June
30,  2005  and  2004  the  Company  recorded  $830,616  and  $1,632,200  for the
14,192,327  and  1,980  shares  issued  to  employees.  The Company also charged
expenses  of  $449,295  and  $401,813  relating  to  these  issuances.

All  of  the  above  share  information  has  been  adjusted to reflect the post
consolidation  of 900:1 on December 3, 2004 and  350:1  on  March  10,  2005
and the forward split of 3:1 on May  3,  2005.

PREFERRED STOCK

Series  A  shares  are  convertible into 10 shares of common stock. The Series A
preferred  stock will have one vote per share on all matters submitted to a vote
of  the  holders of common stock, including, without limitation, the election of
directors.  At  June  30,  2005  and  December  31,  2004  there  were 2,497,700
and  2,437,700  shares  issued  and  outstanding,  respectively.

During  the  six  months ended June 30, 2004, the Company issued an aggregate of
154,700  shares  of series a preferred stock in exchange of debt for $3,022,550.

During  the  six  months ended June 30, 2005, the Company issued an aggregate of
60,000  shares  of  series  a  preferred stock for various professional services
valued  at $900. The Company valued the shares issued at $0.015 per share, which
approximated  the fair value of the services rendered. The compensation costs of
$900  were  charged  to  operations  during  the six months ended June 30, 2005.

Series  B  shares  are  convertible  into 1 share of common stock.  The Series B
preferred  stock will have one vote per share on all matters submitted to a vote
of  the  holders of common stock, including, without limitation, the election of
directors.  During  the six months ended June 30, 2005 the Company issued 50,000
shares  in  exchange  for  a Convertible Debenture and Accrued Interest totaling
$36,300.  At  December  31,  2004  there  were no shares issued and outstanding.

Series  C  shares  have  no  conversion rights into shares of common stock. Each
share  of  Series  C preferred stock will have voting rights equal to 500  votes
per  share of common stock on all matters submitted to  a  vote  of  the holders
of  common  stock,  including,  without limitation, the election  of  directors.

At  June 30,  2005  and  December  31,  2004  there were 10,000,000  shares of
series  C  preferred  stock  issued  and  outstanding,  respectively.


NOTE  H  -  NON QUALIFIED STOCK COMPENSATION PLAN

In  May  2005, the Company authorized the Non-Employee Directors and Consultants
Retainer  Plan  ("NDCRP")  for  the  Year  2005.  The purpose of the NDRCP is to
attract  non-employee directors and consultants who are capable of improving the
success  of  the  Company  by  providing  a  direct economic interest to Company
performance.  Under the terms of the plan, non-employee directors or consultants
may  be compensated through the issuance of Company stock at Market Value on the
date  of issuance. The plan is administered by the Company's Board of Directors.


                                      -10-
<PAGE>
NOTE  I  -  RELATED PARTY TRANSACTIONS

The  Company  advance  funds  to  related  entities  for business development or
reimbursement  of  expenses.  During six months ended June 30, 2005, the Company
has  reimbursed net $182,523 to related parties. The Company provides management
and  consulting  services  under  agreements  with  entities  controlled  by the
Company's  President.  The  Company's  management  has  determined  that  the
collectibility  and length of time to collect the amount due from these entities
can not be reasonably assured. Accordingly, revenues are recognized as collected
in connection with the services rendered. During the periods ended June 30, 2005
and  2004, the Company did not receive nor recognize revenues in connection with
providing  these  services.

At  June  30,  2005  and  December  31,  2004  accounts  payable-related  party
outstanding  balances  of  $103,656  and  $1,600  respectively.  These  amounts
represent  funds  advanced  by  an  Officer  for  operating  expenses.

During  the  periods  ended  June 30, 2005 and 2004 the employees of the Company
were  paid  through   entities  owned by the Company's President. These entities
are  responsible  for payroll, all payroll taxes, health insurance plans and all
other  employee benefits.  During  the six  months ended  June 30, 2005 and 2004
the  Company  paid  these  entities  approximately  $220,986  and  $182,380
respectively,  which  has  been charged to operations. At June 30, 2005, $20,885
was  owed  to  the  related  entity  (included  in accounts payable) for payroll
expenses.  There  were  no  amounts  due  to these entities as of June 30, 2004.


NOTE  J  -  RESTATEMENT

During the audit of the  Company's  financial  statements  for the twelve months
ended December 31, 2004,  the Company made accounting  adjustments  for  certain
transactions  that  occurred  during  the  six  months  ended  June  30, 2004 as
follows:

-    Recorded  Employee  stock  options  at Fair Market Value at the date of the
     grant  less  cash  received  from the employee exercise. Increased Employee
     Stock  Option  expense $401,812 and increased Additional Paid in Capital by
     $401,812.
-    Recorded  Preferred  Series shares issued for debt at the fair market value
     of  the  shares  at  the  date  agreements were made with creditors to take
     shares  in  exchange  for their debts. The effect of this adjustment was to
     increase  the  Accumulated  Deficit  at  December  31,  2003 by $2,809,824,
     decrease  Debt  Forgiveness income by $285,641 and increase Additional Paid
     In  Capital  by  $3,095,465  for  the  six  months  ended  June  30,  2004.
-    Adjusted  Other  Obligations  by  negotiating  the  cancellation of certain
     shares  to be issued to a related party and others. This adjustment reduced
     Debt  Forgiveness  by $135,600 and increasing Additional Paid in Capital by
     $135,600.
-    Adjusted  Common  Stock to reflect the 900:1 and 350:1 reverse stock splits
     on  December  3,  2004 and March 10, 2005, respectively and the 3:1 forward
     stock  split  on  May 3, 2005. This adjustment increased Additional Paid in
     Capital  by  $414,223  and  decreased  Common  Stock  by  $414,223.
-    Adjusted  the  Par Value of Preferred Series A and C to reflect the correct
     par  value.  This adjustment decreased the Par Value of Series A by $1,005,
     Series  C  by  $5,000  and  increased Additional Paid in Capital by $6,005.

The net effect of these adjustments for the six months ended June 30, 2004 are
as follows:

<TABLE>
<CAPTION>
                                                                   Six Months Ended
                                                                    June 30, 2004
                                                             As Originally
                                                                Reported       Restated
                                                             -------------  -------------
<S>                                                          <C>            <C>

Total Assets                                                 $    264,111   $    264,111
                                                             -------------  -------------

Liabilities and Other Obligations                                 915,070        915,070
                                                             -------------  -------------

Common Stock                                                      414,227              4
Preferred Series A                                                  2,140          1,135
Preferred Series C                                                 10,000          5,000
Additional Paid in Capital                                     22,215,904     26,269,009
Accumulated Deficit                                           (23,293,230)   (26,926,107)
                                                             -------------  -------------
Total Liabilities and (Deficiency) in Stockholders' Equity   $    264,111   $    264,111
                                                             -------------  -------------

Net (Loss)                                                   $   (548,083)  $ (1,371,136)
                                                             -------------  -------------

Loss Per Share - Basic and Diluted                           $       (.00)  $    (571.31)
                                                             -------------  -------------
</TABLE>


                                      -11-
<PAGE>
NOTE K - BUSINESS SEGMENTS

The  Company  reports  its  businesses  as  three  reportable  segments:
BUSINESS  DEVELOPMENT:  This segment provides management, financing and business
advice  to  other  business  units  and  subsidiaries  for  a  fee.
HEALTH  AND  NUTRITION  PRODUCTS:  This  segment  consists  of consumer products
designed  to  promote  good  health  and  wellness.
RIVET  TOOLS  AND MAGAZINES: This segment consists of manufactured products sold
the  manufacturing  industry  to improve the riveting process through the use of
the  Company's  patented  riveting  process.

Segment  operating income is total segment revenue reduced by operating expenses
identifiable  with  the  business  segment. Corporate includes general corporate
administrative  costs.

The  Company  evaluates performance and allocates resources based upon operating
income. The accounting policies of the reportable segments are the same as those
described  in  the  summary  of  accounting policies. There are no inter-segment
sales.  The  following  table summarizes segment asset and operating balances by
reportable  segment:

<TABLE>
<CAPTION>
                                                     2005          2004
                                                -------------  ------------
<S>                                             <C>            <C>
     Net Sales to External Customers:
        Health and Nutrition Products           $        599   $         -
     Total Sales to External Customers          $        599   $         -
                                                =============  ============

     Depreciation and Amortization:
     Business Development                       $          -   $         -
     Helth and Nutrition Products                          -             -
     Revit Guns and Rivets                                 -             -
                                                -------------  ------------
     Total Depreciation and Amortization        $          -   $         -
                                                =============  ============

     General and Administrative Expense:
     Business Development                       $  1,281,755   $ 1,987,268
     Health and Nutrition                             29,068             -
     Rivet Guns and Rivets                                 -             -
                                                -------------  ------------
     Total General and Administrative Expense   $  1,310,823   $ 1,987,268
                                                =============  ============

     Capital Expenditures:
     Business Development                       $          -   $         -
     Health and Nutrition                                  -             -
     Rivet Guns and Rivets                                 -             -
                                                -------------  ------------
     Total Capital Expenditures                 $          -   $         -
                                                =============  ============

     Operating (Loss):
     Business Development                       $ (1,282,273)  $(1,987,268)
     Health and Nutrition                            (29,068)            -
     Rivet Guns and Rivets                                 -             -
                                                -------------  ------------
     Total Operating (Loss)                     $ (1,311,341)  $(1,987,268)
                                                =============  ============

     Segment Assets:
     Business Development                       $      1,653   $    58,601
     Health and Nutrition                             21,798             -
     Rivet Guns and Rivets                         4,922,392             -
                                                -------------  ------------
     Total Segment Assets                       $  4,945,843   $    58,601
                                                =============  ============
</TABLE>


                                      -12-
<PAGE>
NOTE  L  -  GOING  CONCERN

The  accompanying  statements have been prepared on a going concern basis, which
contemplates  the  realization  of assets and the satisfaction of liabilities in
the  normal course of business. As shown in the condensed consolidated financial
statements during the six months ended June 30, 2005 the Company incurred a loss
of  $1,315,780. The Company's current liabilities exceeded its current assets by
$2,706,298 as of June 30, 2005. These factors among others may indicate that the
Company will be unable to continue as a going concern for a reasonable period of
time.

The  Company's  existence  is  dependent  upon  management's  ability to develop
profitable operations and resolve its liquidity problems. Management anticipates
the  Company will attain profitable status and improve its liquidity through the
continued  developing,  marketing  and  selling  of  its products and additional
equity  investment  in the Company. The accompanying financial statements do not
include  any  adjustments  that  might  result  should  the Company be unable to
continue  as  a  going  concern.

In  order  to  improve  the Company's liquidity, the Company is actively pursing
additional  equity  financing  through  discussions  with investment bankers and
private  investors.  There can be no assurance the Company will be successful in
its  effort  to  secure  additional  equity  financing.

If  operations  and  cash  flows  continue  to  improve  through  these efforts,
management  believes  that  the  Company  can  continue  to operate. However, no
assurance  can  be  given  that  management's  actions will result in profitable
operations  or  the  resolution  of  its  liquidity  problems.


NOTE M - COMMITMENT AND CONTINGENCIES

On  January 21, 2005, Plaintiff Investrend Communications, Inc. d/b/a Investrend
Research  commenced an action via Verified Complaint in the Supreme Court of the
State  of New York, County of Queens, against ATNG, Inc.  The complaint, through
three  causes  of action, essentially alleges a breach of contract and seeks the
amount  of  $21,625.00  as  well as reasonable attorneys' fees and consequential
damages.

The  Company  has formed a strategic alliance with Statewide Residential Lending
to originate residential mortgages throughout the State of Michigan. The Company
entered  in  to  an  agreement  to  manage  and  operate  several  Branches.


ITEM  2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS.

FORWARD-LOOKING INFORMATION

Much of the discussion in this Item is "forward looking" as that term is used in
Section 27A of the Securities Act and Section 21E of the Securities Exchange Act
of  1934.  Actual  operations  and  results  may  materially differ from present
plans  and  projections  due  to  changes  in  economic conditions, new business
opportunities,  changed  business  conditions,  and  other  developments.  Other
factors  that  could  cause  results  to  differ materially are described in our
filings  with  the  Securities  and  Exchange  Commission.

There  are  several  factors  that  could  cause  actual  results  or  events to
differ  materially  from  those anticipated, and include, but are not limited to
general  economic,  financial and business conditions, changes in and compliance
with  governmental  laws  and  regulations,  including various state and federal
environmental  regulations,  our  ability  to  obtain  additional financing from
outside  investors and/or bank and mezzanine lenders and our ability to generate
sufficient  revenues  to  cover  operating  losses  and  position  us to achieve
positive  cash  flow.

Readers  are  cautioned  not  to  place  undue  reliance  on the forward-looking
statements  contained herein, which speak only as of the date hereof. We believe
the  information  contained  in this Form 10-QSB/A to be accurate as of the date
hereof.  Changes  may occur after that date. We will not update that information
except  as  required  by  law  in  the  normal  course  of its public disclosure
practices.

Additionally,  the  following  discussion  regarding our financial condition and
results  of  operations  should  be  read  in  conjunction  with  the  financial
statements  and  related  notes  contained  in  Item  1  of  Part I of this Form
10-QSB/A,  as  well as the financial statements in Item 7 of Part II of our Form
10-KSB  for  the  fiscal  year  ended,  2  December  31,  2004.


                                      -13-
<PAGE>
MANAGEMENT'S  PLAN  OF  OPERATIONS

GENERAL

Zann Corp is approximately two and a half years into a turnaround period. During
2004,  we  made  great  progress  in  our  turnaround and revitalization plan by
settling  $9,000,000.00  in  debt  and  legal  exposure  inherited  from  prior
management,  with  the  exception  of  $235,000 in payroll taxes and $116,000 in
salaries.  We  expect  these  issues  to  be completely settled within 12 months
without  expending  any  cash.  Most  of  the liabilities currently shown in the
financials  are  expected  to  be  written  off  as their statute of limitations
allows.  One  legal  issue  from  prior  management  remains  pending.

RECENT CHANGES IN OUR CORPORATE STRUCTURE

Effective  March  10,  2005,  we  implemented a one for 350 reverse split of our
authorized,  issued  and  outstanding  shares  of  common  stock  by  filing  a
Certificate  of  Change  with  the  Secretary  of  State of Nevada (the "Reverse
Split.")  Following  the  Reverse  Split, the number of authorized shares of our
common  stock was reduced to 11,428,572 in accordance with the one for 350 split
ratio.  The  number  of our authorized preferred shares remained at 350,000,000,
and the par value of our common and preferred stock remained at $0.001 per share
following  the  Reverse  Split.

     All  fractional  shares  which  would otherwise be held by our stockholders
following  the  Reverse  Split were rounded up to one whole share. We issued one
new  share  of common stock for up to each 350 shares of common stock held as of
March  9,  2005.

     Effective  May 3, 2005, we implemented a three for one forward split of our
authorized,  issued  and  outstanding  shares  of  common  stock  by  filing  a
Certificate  of  Change  with  the  Secretary  of  State of Nevada (the "Forward
Split").  Following  the  Forward  Split, the number of authorized shares of our
common  stock  was  increased to 34,285,716 in accordance with the three for one
split  ratio.  The  number  of  our  authorized  preferred  shares  remained  at
350,000,000,  and  the  par  value of our common and preferred stock remained at
$0.001  per  share  following  the  Forward  Split.

     The  Forward Split was a mandatory exchange. Our stockholders were required
to surrender stock certificates representing their shares of our common stock in
order to receive stock certificates representing their post-Forward Split shares
of  the  Registrant's  common  stock.

Effective  May  9, 2005, we increased the number of our authorized common shares
from 34,285,716 to 4,000,000,000 by filing Articles of Amendment to our Articles
of  Incorporation  with  the  Secretary  of  State  of Nevada. The number of our
authorized  preferred  shares  remained at 350,000,000, and the par value of our
common  and  preferred stock remained at $0.001 per share following the increase
in  the  number  of  our  authorized  common  shares.

STRUCTURE

The  company  has  four  current  business  units:

Monoclonal  antibodies  and  gene  therapy
------------------------------------------

The  research  of our diagnostic development division resulted in the discovery,
identification, and characterization of novel microbial agents. This bacterium's
working  title is "human blood-borne bacterium-1" (HBB1), and it is persistently
present  in  the  human bloodstream. The levels of HBB-1 appear to be associated
symptom  activity  in Multiple Sclerosis (MS) patients and other disorders, such
as  Chronic  Fatigue  Syndrome (CFS) and certain autoimmune diseases. It has the
Company  taken  several  years  and several million dollars to characterize this
organism  and to produce antibodies. Now we can accelerate our commercialization
in  the  area  of  production  and sale of monoclonal and polyclonal antibodies.

Nutritional  supplements
------------------------

We  completed the acquisition of Blue Kiwi Inc. in the 3rd Quarter of 2004. Blue
Kiwi  is  a  nutraceutical company and currently has two products on the market,
the  Fatigue  Pack(R) and the PMS Pack(TM). Our new product development team has
24  additional  products  in  the  prototype state. We expect to launch these 24
products  as  resources  allow.

Financial  services  (development  stage)
-----------------------------------------

ZANN  Corp  has  recently formed a strategic alliance with Statewide Residential
Lending to originate residential mortgages throughout the State of Michigan. The
Company  has  an  agreement to manage and operate several Branches, the first of
which  is  in  Fenton.  We  have  already  hired  several  Loan  Officers  whose
professionalism  will  enable  us  to  commence  doing  business  immediately.
Additionally,  we are involved in negotiations with several experienced mortgage
professionals  from  various lenders such as Washington Mutual, Countrywide, and
Flagstar Bank. We expect the financial services team to be profitable in the 3rd
quarter  2005  and  gross  revenues  of  $1,000,000  in  2006.

Sartam  Industries-AutoFast  Inc.  (planned  acquisition).
----------------------------------------------------------

We  have recently purchased 48% of the Common stock and 6.52% of the Convertible
Preferred  Second  Series  stock of Sartam Industries, Inc.  Sartam is the world
patent  owner  of the AutoFast 2000 semi-automatic riveting technology.  We have
signed  a  "Letter  of  Intent"  with  Sartam  and  are working on a "Definitive
Agreement"  to  purchase the balance of Sartam stock.  An audit will be required
as  one  of  the  significant  steps  in  the  acquisition  process.

At  present,  Zann  Corp.  is  building  tools  and  rivet  magazines  under the
AutoFast(R) brand name. AutoFast(R) has started to ship magazines this month and
expects  purchase  orders  to  grow  rapidly  with  production  capacity.

OBJECTIVES

Our  current  objectives  are  to:
     -    Raise  operating  capital  to  launch  Sartam-AutoFast(R)  Products;
     -    Manage  legal  issues,  one  new  and  one  inherited  from  the prior
          management  team;
     -    Achieve  profitability  in  2005  as  per  plan;
     -    Create  shareholder  value.


                                      -14-
<PAGE>
TECHNOLOGY  AND  PATENTS

We  have three promising patents, one for a blood-borne bacteria associated with
multiple  sclerosis  and  chronic  fatigue syndrome, one for an activating virus
associated  with  AIDS  and  several  cancers,  and  one  for analog compression
technology.  The  most  promising  of  these is the bloodborne bacterium patent.

     -    Compression Technology, Patent Number US 6,724,326 B1, dated April 20,
          2004,  assigned  to  ZANN  Corp.  on  February 21, 2005, serial number
          10/345,834;

     -    Human  Blood  Bacterium,  Patent Number US 6,255,467 B1, dated July 3,
          2001,  assigned  to  ZANN  Corp.  on  February 21, 2005, serial number
          09/187,946;  and

     -    Human  and Marmoset Activating Viruses, Patent Number US 6,177,081 B1,
          dated  January  23, 2001, assigned to ZANN Corp. on February 21, 2005,
          serial  number  08/901,128.

There  are  a  number of Sartam patents; detailed information to be posted after
audit  is  complete.

OVERVIEW
Each  of Zann Corp.'s business units own proprietary, scalable technologies with
a  significant  potential  for growth and profits. Our mission is to develop and
accelerate  the  growth  of  each  unit.  The company manages functions of these
organizations,  performing marketing, human resource, finance, customer service,
administration,  sales,  and most other normal company operations. The ZANN Corp
team  of  employees,  expert consultants, advisors, and selected vendors is well
qualified to execute our business plan and grow the combined business within the
foreseeable  future.

RESULTS OF OPERATIONS

CONTINUING OPERATIONS

REVENUE

SIX MONTHS ENDED JUNE 30, 2005 COMPARED TO THE SIX MONTHS ENDED JUNE 30,
2004.

Total  net  sales and revenues were  $599 for the six months ended June 30, 2005
compared  to  $0 for the period ended June 30, 2004, an increase of 599 percent.

Our  gross profit (loss) for the six months ended June 30, 2005 compared to 2004
decreased  to  $(518)  from $0.  Gross (loss) as a percentage of sales increased
to  (86)  percent  in  2005  from  0  percent  in  2004.

Total operating expenses for the six months ended June 30, 2005 compared to 2004
decreased  by  $676,445  to  $1,310,823  from  $1,987,268  in  the prior period.

Operating  loss  decreased from a loss of $1,987,268 to a loss of $1,311,341 for
the  six  months ended June 30, 2005 compared to the period ended June 30, 2004.

Interest  expense,  net  for  the  six  months ended June 30, 2005 was $4,439 as
compared  to  $0  for  the  same  period  of  2004.

Net  loss  from  continuing  operations  for  the six months ended June 30, 2005
decreased to a loss of $1,315,780 from a loss of $1,371,136 compared to the same
period  2004.

SETTLEMENT OF DEBTS AND LIABILITIES

We  continued  to  pursue  an active program to settle all outstanding debts and
liabilities  from the predecessor company.  During the years ended December  31,
2004  and  December  31,  2003,  a  number  of  debts  were  settled  by partial
payments  of  cash  or issuance  of Common or preferred Stock.  We will continue
to  pursue  the same course during 2005 and until all debts have been settled or
forgiven.


                                      -15-
<PAGE>
LIQUIDITY AND CAPITAL RESOURCES

As  of  June  30,  2005,  we  had a deficiency in working capital of $2,706,298.
During  the  six  months  ended  June  30,  2005  we raised $100,000 through the
issuance  of  a one year 10% Convertible Debenture for working capital.  We also
paid  $4,440 of interest and made $1,615 payments on the principal balance.  The
Debenture  is convertible into shares of Series a Preferred stock at $.663 cents
per  share  at  the  option  of  the  holder.

We  also  received  $355,937  from  the exercise of employee stock options.  The
proceeds  were  used  for  working  capital.

Cash  used  in investing activities was $199,605 and none was used for property,
plant,  and  equipment.  Payments  on  a  Convertible  Debenture totaled $1,615.

AUDITOR'S OPINION EXPRESSES DOUBT ABOUT THE COMPANY'S ABILITY TO CONTINUE AS A
"GOING CONCERN"

The  independent  auditors  report on our December 31, 2004 financial statements
included  in  the  Company's  Annual Report states that the Company's historical
losses  and  the  lack  of revenues raise substantial doubts about the Company's
ability  to  continue  as  a  going  concern.  If  we  are unable to develop our
business,  we  have  to discontinue operations or cease to exist, which would be
detrimental  to  the  value  of  the  Company's  common  stock.  We  can make no
assurances  that  our  business  operations  will  develop  and  provide us with
significant  cash  to  continue  operations.

CRITICAL ACCOUNTING POLICIES

The  preparation  of  our  consolidated  financial statements in conformity with
accounting  principles  generally  accepted  in the United States requires us to
make  estimates  and  judgments  that  affect  our reported assets, liabilities,
revenues, and expenses, and the disclosure of contingent assets and liabilities.
We  base  our  estimates  and  judgments on historical experience and on various
other  assumptions  we  believe to be reasonable under the circumstances. Future
events,  however,  may  differ  markedly  from  our  current  expectations  and
assumptions.  While  there  are  a  number  of  significant  accounting policies
affecting  our  consolidated  financial  statements,  we  believe  the following
critical  accounting  policy  involve the most complex, difficult and subjective
estimates  and  judgments.

STOCK-BASED COMPENSATION

In  December  2002,  the  FASB  issued SFAS No. 148 - Accounting for Stock-Based
Compensation  - Transition and Disclosure.  This statement amends SFAS No. 123 -
Accounting  for  Stock-Based  Compensation,  providing  alternative  methods  of
voluntarily  transitioning  to  the fair market value based method of accounting
for  stock based employee compensation.  FAS 148 also requires disclosure of the
method  used  to account for stock-based employee compensation and the effect of
the  method in both the annual and interim financial statements.  The provisions
of  this  statement related to transition methods are effective for fiscal years
ending  after  December  15,  2002,  while  provisions  related  to  disclosure
requirements  are  effective  in financial reports for interim periods beginning
after  December  31,  2002.  We  elected  to continue to account for stock-based
compensation  plans  using  the  intrinsic  value-based  method  of  accounting
prescribed  by  APB  No.  25,  "Accounting  for  Stock Issued to Employees," and
related  interpretations.  Under  the  provisions  of  APB  No. 25, compensation
expense  is measured at the grant date for the difference between the fair value
of  the  stock  and  the  exercise  price.

On  December  16,  2004,  the  Financial  Accounting  Standards  Board  (FASB)
issued  FASB Statement No. 123R (revised 2004), "Share-Based Payment" which is a
revision  of  FASB Statement No. 123, "Accounting for Stock-Based Compensation".
Statement  123R  supersedes  APB opinion No. 25, "Accounting for Stock Issued to
Employees",  and  amends  FASB  Statement  No.  95,  "Statement  of Cash Flows".
Generally,  the  approach in Statement 123R is similar to the approach described
in  Statement  123. However, Statement 123R requires all share-based payments to
employees,  including  grants of employee stock options, to be recognized in the
income  statement  based on their fair values. Pro-forma disclosure is no longer
an  alternative.  On  April  14, 2005, the SEC amended the effective date of the
provisions  of  this statement.  The effect of this amendment by the SEC is that
the  Company  will  have  to  comply  with Statement 123R and use the Fair Value
based  method  of  accounting  no  later  than  the  first  quarter  of  2006.
Management  has  not  determined  the  impact  that  this statement will have on
Company's  consolidated  financial  statements.


                                      -16-
<PAGE>
NEW  ACCOUNTING  PRONOUNCEMENTS

In March 2005, the FASB issued FASB Interpretation (FIN) No. 47, "Accounting for
Conditional  Asset  Retirement  Obligations, an interpretation of FASB Statement
No.  143,"  which requires an entity to recognize a liability for the fair value
of  a  conditional  asset retirement obligation when incurred if the liability's
fair  value  can  be  reasonably estimated. The Company is required to adopt the
provisions  of FIN 47 no later than its last quarter of fiscal 2006. The Company
does not expect the adoption of this Interpretation to have a material impact on
its  consolidated  financial  position,  results  of  operations  or cash flows.

In  May  2005 the FASB issued Statement of Financial Accounting Standards (SFAS)
No. 154, "Accounting Changes and Error Corrections, a replacement of APB Opinion
No. 20 and FASB Statement No. 3." SFAS 154 requires retrospective application to
prior  periods' financial statements for changes in accounting principle, unless
it  is  impracticable  to  determine  either  the period-specific effects or the
cumulative  effect  of  the  change.  SFAS  154 also requires that retrospective
application of a change in accounting principle be limited to the direct effects
of  the  change. Indirect effects of a change in accounting principle, such as a
change in non-discretionary profit-sharing payments resulting from an accounting
change,  should  be  recognized in the period of the accounting change. SFAS 154
also  requires  that a change in depreciation, amortization, or depletion method
for  long-lived, non-financial assets be accounted for as a change in accounting
estimate effected by a change in accounting principle. SFAS 154 is effective for
accounting  changes  and  corrections  of  errors made in fiscal years beginning
after  December 15, 2005. Early adoption is permitted for accounting changes and
corrections  of  errors  made  in  fiscal  years  beginning  after the date this
Statement  is  issued.  The Company does not expect the adoption of this SFAS to
have  a  material  impact  on  its  consolidated  financial position, results of
operations  or  cash  flows.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements.

INFLATION

In  the  opinion  of  management, inflation has not had a material effect on the
operations  of  the  Company.

ITEM 3.   CONTROLS AND PROCEDURES.

Disclosure  controls  and  procedures are controls and other procedures that are
designed  to  ensure  that  information  required  to  be disclosed by us in the
reports  that  we  file or submit under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the Securities and
Exchange  Commission's  rules  and  forms.  Disclosure  controls  and procedures
include,  without  limitation,  controls  and procedures designed to ensure that
information required to be disclosed by us in the reports that we file under the
Exchange  Act  is


                                      -17-
<PAGE>
accumulated  and  communicated  to  our  management,  including  our  principal
executive  and  financial  officers,  as  appropriate  to allow timely decisions
regarding  required  disclosure.

Evaluation  of  Disclosure  and  Controls  and Procedures.  As of the end of the
period  covered  by this Quarterly Report, we conducted an evaluation, under the
supervision  and with the participation of our chief executive officer and chief
financial  officer,  of  our  disclosure  controls and procedures (as defined in
Rules  13a-15(e)  of  the  Exchange  Act).  Based  on this evaluation, our chief
executive  officer  and  chief  financial  officer concluded that our disclosure
controls  and procedures are effective to ensure that information required to be
disclosed  by  us  in  reports  that we file or submit under the Exchange Act is
recorded,  processed,  summarized and reported within the time periods specified
in  Securities  and  Exchange  Commission  rules  and  forms.

Changes  in  Internal  Controls over Financial Reporting. There was no change in
our  internal  controls,  which  are  included  within  disclosure  controls and
procedures,  during  our  most  recently  completed  fiscal  quarter  that  has
materially  affected, or is reasonably likely to materially affect, our internal
controls.


PART II - OTHER INFORMATION

ITEM  1.   LEGAL PROCEEDINGS.

On  December  28, 2004, R. Patrick Liska filed a lawsuit in a Minnesota District
Court  asserting  claims  against the Company and a third party. The lawsuit has
since  been  transferred  to  the United States District Court in Minnesota. The
lawsuit  alleges  that  Mr.  Liska served as a director and Vice Chairman of the
Board  of the Company in 2004. The lawsuit seeks recovery of 1,000,000 shares of
the  Company's  series  a convertible preferred stock, salary, vacation pay, and
various  business expense reimbursements. Additionally, the lawsuit alleges that
the  Company  was  engaged  in a joint enterprise with the third party, and as a
result,  the  Company  is  liable for any salary, vacation pay, stock grants, or
expense  reimbursements allegedly due and owing to Mr. Liska by the third party.
All of the operative allegations in the lawsuit have been denied by the Company.
Because this proceeding is in its initial stage, it is difficult to predict with
any  degree  of certainty the potential liabilities, if any, associated with the
lawsuit.

On  January 21, 2005, Plaintiff Investrend Communications, Inc. d/b/a Investrend
Research  commenced an action via Verified Complaint in the Supreme Court of the
State  of  New York, County of Queens, against ATNG, Inc. The complaint, through
three  causes of action, essentially alleges a breach of contract. Specifically,
it  alleges that ATNG, Inc. did not pay Plaintiff for providing news coverage of
ATNG,  Inc.  At  the  current  time,  the parties are engaged in motion practice
regarding  Plaintiff's  efforts  to  strike  Defendant's  affirmative  defenses.
Further,  on  July  18,  2005,  Defendant  served  upon Plaintiff, its Notice of
Discovery and Inspection and Notice of Deposition. Plaintiff seeks the amount of
$21,625.00  as  well  as  reasonable  attorneys' fees and consequential damages.


ITEM  2.   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On May 16, 2005, the Company entered into an agreement with Marshall Richardson,
whereby  Marshall  Richardson  accepted  50,000 shares of the Company's Series B
preferred  stock in exchange for a convertible debenture dated April 1, 2003 for
180,000  shares  at  12  percent  with  a  conversion date of April 1, 2005 (the
"Convertible Debenture"). Marshall Richardson received the Convertible Debenture
on  April  1,  2003, in exchange for the promissory note for $25,000 in favor of
Marshall  Richardson,  executed  by  the  Company  on  or  about  June  of 2002.

On  July 1, 2005, the Company executed a Subscription Agreement for the Series B
Preferred  stock of the Company pursuant to which two private investors received
10,000  shares  of  the  Series  B  Preferred stock in exchange for $10,000. The
$10,000  was  used  for  working  capital.

Each  share of the Series B preferred stock is convertible into one share of our
common  stock.  On  all matters submitted to a vote of the holders of our common
stock,  including,  without  limitation,  the election of directors, a holder of
shares  of  the  Series  B preferred stock is entitled to the number of votes on
such  matters equal to the number of shares of the Series B preferred stock held
by  such holder. The shares of the Series B preferred stock rank superior to the
shares  of  our  common  stock,  and  to  the  shares of all other series of our
preferred  stock.The  shares  of  the  Series  B  Preferred stock were issued in
reliance  upon  an  exemption  from registration pursuant to Section 4(2) of the
Securities  Act.  All  of  the  investors  took  their securities for investment
purposes without a view to distribution and had access to information concerning
Zann  Corp.  and  our  business  prospects,  as  required by the Securities Act.

In  addition,  there was no general solicitation or advertising for the purchase
of  our  shares.  Our  securities  were  sold only to persons with whom we had a
direct  personal  preexisting  relationship,  and  after  a thorough discussion.
Finally,  our  stock  transfer  agent has been instructed not to transfer any of
such  shares,  unless  such  shares  are  registered  for  resale or there is an
exemption  with  respect  to  their  transfer.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.

ITEM  4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

     Effective  May  9,  2005,  the  holder  of  the majority of our outstanding
capital  stock,  voted  to  approve  the  following  corporate  actions:

1.  An  amendment  to  our  articles of incorporation to increase the authorized
number  of  shares  of  our  common  stock from 11,428,572 to 4,000,000,000; and

2  Grant  of  discretionary  authority  to our board of directors to implement a
reverse  split  of our common stock on the basis of one post-consolidation share
for  up  to  each  350  pre-consolidation shares to occur at some time within 12
months  of the date of the Company's information statement on Schedule 14C, with
the  exact time of the reverse split to be determined by the board of directors.

We  had  a  consenting  stockholder,  Robert  C. Simpson, Ph. D., our president,
secretary,  chairman  of the board of directors and chief financial officer, who
held  62,858  shares  of  our  common  stock,  1,800,000  shares of our Series A
preferred  stock,  and  10,000,000 shares of our Series C preferred stock on the
record  date  for  the forementioned corporate actions. Each share of our common
stock  is  entitled  to one vote on all matters brought before the stockholders,
each  share  of  our Series A preferred stock outstanding entitles the holder to
one vote of the common stock on all matters brought before the stockholders, and
each  share  of  our Series C preferred stock outstanding entitles the holder to
500  votes  of  the common stock on all matters brought before the stockholders.
Therefore,  Dr. Simpson had the power to vote 5,001,862,858 shares of the common
stock,  which  number  exceeded  the  majority  of  the  4,228,861  issued  and
outstanding  shares of our common stock on the record date for the forementioned
corporate  actions.

     Dr.  Simpson  voted  in  favor of the proposed amendment to our articles of
incorporation  and  for the grant of discretionary authority with respect to the
stock split. Dr. Simpson had the power to approve the proposed corporate actions
without  the  concurrence  of  any  of  our  other  stockholders.


                                      -18-
<PAGE>
ITEM  5.   OTHER INFORMATION.

     None.

ITEM  6.   EXHIBITS.

<TABLE>
<CAPTION>
 EXHIBIT NO.                                       IDENTIFICATION OF EXHIBIT
-----------  ---------------------------------------------------------------------------------------------------
<C>      <S>

3.1 **   Articles of Incorporation
3.2 **   Articles of Amendment to Articles of Incorporation
3.3 **   Articles of Amendment to Articles of Incorporation
3.4 **   Certificate of Designation establishing our Series A Preferred Stock, filed effective August 24, 2004
3.5 **   Certificate of Designation establishing our Series C Preferred Stock, filed effective August 24, 2004
3.6 **   Certificate of Amendment to the Certificate of Designation establishing our Series C Preferred Stock,
           filed effective March 21, 2005
3.7 **   Articles of Amendment to our Articles of Incorporation, filed effective on December 3, 2004
3.8 **   Certificate of Designation establishing our Series B Preferred Stock, filed effective on March 8, 2005
3.9 **   Certificate of Change, filed effective on March 10, 2005
3.10 **  Certificate of Change, filed effective on May 3, 2005
3.11 **  Articles of Amendment to Articles of Incorporation, filed effective on May 9, 2005.
10.1 **  Blue Kiwi Acquisition Agreement
10.2 **  Investra Articles of Merger
10.3 **  Pathobiotek Acquisition Agreement
10.4 **  Sartam Stock Purchase Agreement
10.5 **  Sartam Promissory Note
10.6 **  Sartam Stock Pledge Agreement
10.7 **  Sartam Escrow Agreement
10.8 **  Consulting Agreement between Zann Corp. and Charles Duke
10.9 **  Consulting Agreement between Zann Corp. and Jonathon Derek Seltzer
10.10 ** Contribution and Assumption Agreement between Robert C. Simpson and Zann Corp.
31.1 *   Certification of Robert C. Simpson, President, Secretary, and Chairman of the Board of Directors of
           Zann Corp., pursuant to 18 U.S.C. Sec.1350, as adopted pursuant to Sec.302 of the Sarbanes-Oxley
           Act of 2002
31.2 *   Certification of George E. Betts, Chief Financial Officer of Zann Corp., pursuant to 18 U.S.C.  Sec.1350,
           as adopted pursuant to Sec.302 of the Sarbanes-Oxley Act of 2002
32.1 *   Certification of Robert C. Simpson, President, Secretary, and Chairman of the Board of Directors of Zann
           Corp., pursuant to 18 U.S.C. Sec.1350, as adopted pursuant to Sec.906 of the Sarbanes-Oxley Act of
           2002.
32.2 *   Certification of George E. Betts, Chief Financial Officer of Zann Corp., pursuant to 18 U.S.C.
           Sec.1350, as adopted pursuant to Sec.906 of the Sarbanes-Oxley Act of 2002
</TABLE>

__________
*    Filed  herewith.
**   Previously  Filed


SIGNATURES

     In  accordance  with  the  requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                              ZANN Corp.
Dated: September 8, 2005
                                              By /s/ Robert C. Simpson
                                              -------------------------------
                                              Robert C. Simpson, President and
                                              Chairman of the Board of Directors


                                      -19-


<PAGE>